Position in ABVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$611,796
-$463,733 QoQ
Shares Held
4,591
-52.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#193
of 302 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HIMENSION CAPITAL (SINGAPORE) PTE. LTD. holds $26,011,934 across 20 Biotechnology names. ABVX ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTLA |
Intellia Therapeutics, Inc.
|
326,893 | $5,531,029 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
18,136 | $5,459,480 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
83,897 | $4,575,742 | |
| 4 | MRNA |
Moderna, Inc.
|
25,218 | $1,766,016 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
36,419 | $1,249,900 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
5,653 | $1,058,693 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
50,111 | $937,576 | |
| 8 | ABVX |
Abivax S.A.
This page
|
4,591 | $611,796 |
All Filings in ABVX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $611,796 | 4,591 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,075,529 | 9,659 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,045,126 | 7,750 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,015,573 | 11,962 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||